Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Jan 24 2003
Washington, D.C. (January 24, 2003) – Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO) today announced the establishment of a new...
Jan 22 2003
Washington, D.C. (January 22, 2003) - Wall Street analysts and investors will get their first glimpse of the multibillion-dollar industrial biotechnology...
Jan 9 2003
Washington, D.C. (January 9, 2003) - The Food and Drug Administration (FDA) approved 35 new biotechnology-based drugs and vaccines as well as new indications...
Jan 8 2003
Washington, D.C. (January 8, 2003) – The Biotechnology Industry Organization (BIO) will address the market potential for industrial biotechnology during an...
Dec 27 2002
WASHINGTON, D.C. (December 27, 2002) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today issued the following statement on...
Dec 18 2002
Washington, D.C. (December 18, 2002) – “A new CMS rule slated to take effect January 1 will leave some Medicare patients with yesterday’s...
Dec 17 2002
Washington, DC (December 17, 2002) – The Biotechnology Industry Organization (BIO) is pleased to announce the First Annual Industrial Biotechnology...
Dec 16 2002
WASHINGTON, D.C. (December 16, 2002) − Kathy Stover is the new director of communications for the Biotechnology Industry Organization (BIO) effective...
Dec 10 2002
WASHINGTON, D.C. (December 10, 2002) - A Web cast of selected sessions from the Partnering for Global Health Forum, co-hosted by the Biotechnology Industry...